LONDON, Nov. 25, 2015 /PRNewswire/ -- Over the years, the
antibody production market has witnessed various technological
advancements in order to produce antibodies that meet the needs of
biotechnology and biopharmaceutical companies, diagnostic
laboratories, and research institutes. These advancements have led
to the development of hybridoma-free technologies such as
recombinant technology and antibody phage-display technology. Due
to the advantages of this technology, such as ease of use and
versatility, the hybridoma-free technology is set to replace
technologies that use hybridomas and animals in due course.
In 2014, the consumables segment accounted for the largest share of
the global antibody production market, by product; the monoclonal
antibody segment accounted for the largest share of the antibody
production market, by type; the hybridoma technology segment
accounted for the largest share of antibody production market, by
technology; while the biotechnology and pharmaceutical companies
segment accounted for the largest share of the antibody production
market, by end user.
In 2014, North America accounted
for the largest share of the global antibody production market,
followed by Europe, Asia, and the Rest of the World (RoW). In the
coming years, the antibody production market is expected to witness
the highest growth rate in the Asian region, with emphasis on
India, China, and Japan. These countries are expected to
increase revenues of antibody producers and the manufacturers of
equipment and consumables involved in antibody production.
The global antibody production market witnesses high competitive
intensity as there are several big and many small firms with
similar product offerings. These companies adopt various strategies
(agreements, partnerships, joint ventures, collaborations,
geographical expansions, and acquisitions) to increase their market
shares and to establish a strong foothold in the global market.
Reasons to Buy the Report:
The report will enrich both established firms as well as new
entrants/smaller firms to gauge the pulse of the market, which in
turn helps the firms to garner a greater market share. Firms
purchasing the report could use any one or a combination of the
below-mentioned five strategies (market penetration, product
development/innovation, market development, market diversification,
and competitive assessment) for strengthening their market
shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product
portfolios offered by the top players in the antibody production
market. The report analyzes the antibody production market, by
product, type, technology, and end user
- Product Development/Innovation: Detailed insights on the upcoming
technologies, research and development activities, and new product
launches in the antibody production market
- Market Development: Comprehensive information about the lucrative
emerging markets. The report analyzes the markets for various
antibody production technologies across regions
- Market Diversification: Exhaustive information about new
products, untapped regions, recent developments, and investments in
the antibody production market
- Competitive Assessment: In-depth assessment of the market shares,
strategies, products, distribution networks, and manufacturing
capabilities of the leading players in the antibody production
market
Download the full report:
https://www.reportbuyer.com/product/2913304/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that
provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/antibody-production-market-by-product-type-technology--by-end-user---analysis--global-forecast-to-2019-300184739.html
SOURCE ReportBuyer